The Neutrino Donut is working on a technology assessment relating to the development of new pharmaceutical compounds.
The Neutrino Donut, LLC recently completed a technology assessment of a database used for the evaluation of data in understanding HBV. We viewed opportunities to work with partners as well as creating business structures.
The Neutrino Donut is completing a technology assessment with market develop opportunities on a technology which is used to detect populations resistant to HIV drugs. The innovators are seeking to understand the effect of these drugs on quasispecies. The innovators are seeking to develop a commercially available test.